Oleptiss 360 mg Tablet

About Oleptiss 360 mg Tablet

Oleptiss 360 mg Tablet is an effective treatment option designed to manage chronic iron overload in individuals aged six and older who suffer from transfusion-dependent anemias, making it essential for those requiring frequent blood transfusions. This medication is also suitable for younger patients, specifically those between two to five years old, who have transfusion-dependent anemias and do not respond adequately to deferoxamine therapy. Moreover, Oleptiss 360 mg is beneficial for patients aged ten and above with non-transfusion-dependent thalassemia syndromes, providing a comprehensive approach to iron overload management. By targeting excess iron in the body, Oleptiss helps prevent potential complications associated with iron accumulation, thereby improving overall health and quality of life. It is important to note that while using Oleptiss, patients should be monitored for possible side effects and interactions with other medications. Always consult with a healthcare professional before starting treatment to ensure it aligns with individual health needs and conditions. With its targeted formulation, Oleptiss 360 mg Tablet stands out as a reliable choice for those facing the challenges of chronic iron overload.

Reliable Pharmaceutical Solution for Medical Professionals

Oleptiss 360 mg Tablet is tailored for healthcare providers, distributors, and suppliers looking for dependable medication. Its convenient blister packaging and clear identification make it an excellent choice for clinical settings. Sourced and manufactured in India, this product meets essential standards required for prescription-based therapies.


Designed for Efficient Distribution and Administration

With its oval, yellow tablets and easy-to-handle blister packs, Oleptiss simplifies inventory management for wholesalers and medical suppliers. Each box includes a sufficient quantity for large-scale requirements, supporting hospitals, pharmacies, and export needs.